Eleanor Drummond

11PUBLICATIONS
17CO-AUTHORS
Characterisation of biological macromoleculesNeurology and neuromuscular diseasesNeurosciences not elsewhere classifiedMajor global burdens of diseaseProteomics and metabolomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Sep 24, 2026
Semaphorin 3G (SEMA3G) is a highly selective marker of cerebral amyloid angiopathy.

|Nov 03, 2025
Leveraging Proteomics to Explore the Molecular Mechanisms of Primary Tauopathies.

Laura Nementzik, Tomas Kavanagh, Sian Genoud

|Jun 22, 2025
Differences in the soluble and insoluble proteome between primary tauopathies.

Tomas Kavanagh, Kaleah Balcomb, Stephanie Trgovcevic

|Oct 02, 2024
hnRNP A1, hnRNP A2B1, and hnRNP K are dysregulated in tauopathies, but do not colocalize with tau pathology.

Tomas Kavanagh, Kaleah Balcomb, Diba Ahmadi Rastegar

|Jan 30, 2024
Similar brain proteomic signatures in Alzheimer's disease and epilepsy.

Dominique Leitner, Geoffrey Pires, Tomas Kavanagh

|Jul 25, 2023
Compilation of reported protein changes in the brain in Alzheimer's disease.

Manor Askenazi, Tomas Kavanagh, Geoffrey Pires

Pageof 2

Frequent Collaborators

4 joint publications

Thomas Wisniewski

2 joint publications

Dominique Leitner

2 joint publications

Geoffrey Pires

2 joint publications

Manor Askenazi